http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2019204033-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4d0ce9897f79a6e7dc4638d988496f1 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B65D83-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate | 2019-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_328eb9f09fc370e3118ea1206a158886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8f321635aed156fe91a509a23fd0e0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_268fcd801b6faf9fa2e3a6e8b8531c1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6be18460facfad379fc786f24be1819 |
publicationDate | 2019-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2019204033-A1 |
titleOfInvention | Unit Dosage Package and Methods for Administering Weight Loss Medications |
abstract | Unit dose packaging systems and methods of packaging unit dose pharmaceuticals are provided; in particular, packs are disclosed comprising two unit doses in which a first unit dosage comprises a first and second drug and a second unit dosage comprises said first and second drug, the second drug in a differing amount to the first unit dosage. Preferably, the packaging systems or methods are for the delivery of weight-loss medications, the unit dose form comprises an antidepressant, an anticonvulsant, an antidiabetic and/or an opioid receptor antagonist, the unit dose packaging system is a blister pack, the unit dose is a tablet with a plurality of layers, and/or the unit dose comprises bupropion and at least one of zonisamide and naltrexone. WO2008/060964 PCT/US2007/084178 104 108 104 108 Dos~e2 Dose 1 106 - r106 118- -118 104 108 104 108 104 Dose 1 Dose 2 [ 114-1u ' u 104 Dose 8 Dose 9 K 104 ) |
priorityDate | 2006-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 338.